rho Guanine Nucleotide Dissociation Inhibitor beta
"rho Guanine Nucleotide Dissociation Inhibitor beta" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A rho GDP-dissociation inhibitor subtype that is highly expressed in hematopoietic cells and in LYMPHOCYTES. The expression of this subtype is associated with the regulation of CELL PROLIFERATION; TUMORIGENESIS; and APOPTOSIS.
| Descriptor ID |
D062949
|
| MeSH Number(s) |
D12.644.360.325.225.500.200 D12.776.476.325.225.500.200 D23.050.301.500.600.850 D23.050.705.552.600.700
|
| Concept/Terms |
rho Guanine Nucleotide Dissociation Inhibitor beta- rho Guanine Nucleotide Dissociation Inhibitor beta
- rho GDP-Dissociation Inhibitor beta
- rho GDP Dissociation Inhibitor beta
- rhoGDIbeta
- rho GDP-Dissociation Inhibitor 2
- rho GDP Dissociation Inhibitor 2
- rhoGDI2
- rho Guanine Nucleotide Dissociation Inhibitor 2
- rho GDIbeta
|
Below are MeSH descriptors whose meaning is more general than "rho Guanine Nucleotide Dissociation Inhibitor beta".
Below are MeSH descriptors whose meaning is more specific than "rho Guanine Nucleotide Dissociation Inhibitor beta".
This graph shows the total number of publications written about "rho Guanine Nucleotide Dissociation Inhibitor beta" by people in this website by year, and whether "rho Guanine Nucleotide Dissociation Inhibitor beta" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2011 | 0 | 1 | 1 |
| 2012 | 1 | 0 | 1 |
| 2013 | 1 | 0 | 1 |
| 2017 | 0 | 1 | 1 |
| 2020 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "rho Guanine Nucleotide Dissociation Inhibitor beta" by people in Profiles.
-
Knockdown of RhoGDI2 represses human gastric cancer cell proliferation, invasion and drug resistance via the Rac1/Pak1/LIMK1 pathway. Cancer Lett. 2020 11 01; 492:136-146.
-
Two distinct mTORC2-dependent pathways converge on Rac1 to drive breast cancer metastasis. Breast Cancer Res. 2017 Jun 30; 19(1):74.
-
Rictor encounters RhoGDI2: the second pilot is taking a lead. Small GTPases. 2013 Apr-Jun; 4(2):102-5.
-
Rictor regulates cell migration by suppressing RhoGDI2. Oncogene. 2013 May 16; 32(20):2521-6.
-
Association of D4-GDI expression with breast cancer progression. Cancer Biomark. 2011-2012; 10(3-4):163-73.